Search

Penumbra Inc

Aperta

SettoreSettore sanitario

324.14 0.11

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

322.7

Massimo

324.57

Metriche Chiave

By Trading Economics

Entrata

2.2M

35M

Vendite

15M

390M

P/E

Media del settore

80.584

57.371

EPS

0.88

Margine di Profitto

8.925

Dipendenti

4,700

EBITDA

5.5M

52M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+10.22% upside

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

321M

13B

Apertura precedente

324.03

Chiusura precedente

324.14

Notizie sul Sentiment di mercato

By Acuity

50%

50%

147 / 340 Classifica in Healthcare

Penumbra Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 ago 2026, 00:02 UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

21 ago 2026, 23:31 UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

17 ago 2026, 19:36 UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

10 ago 2026, 19:36 UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

8 ago 2026, 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

7 ago 2026, 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

6 ago 2026, 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

5 ago 2026, 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

4 ago 2026, 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

3 ago 2026, 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24 lug 2026, 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Confronto tra pari

Modifica del prezzo

Penumbra Inc Previsione

Obiettivo di Prezzo

By TipRanks

10.22% in crescita

Previsioni per 12 mesi

Media 358.4 USD  10.22%

Alto 374 USD

Basso 320 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Penumbra Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

6 ratings

1

Acquista

5

Mantieni

0

Vendi

Sentiment

By Acuity

147 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat